Vera Therapeutics, Inc.
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $48.9M | $114.4M | $354.7M | $57.8M | $49.1M | $55.1M | $92.6M | $27.3M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $527.5M | $615.8M | $728.9M | $511.3M | $571.4M | $606.1M | $651.2M | $364.1M |
| Property, Plant & Equipment | $813.0K | $945.0K | $1.4M | $1.2M | $1.2M | $1.1M | $960.0K | $368.0K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $533.0M | $621.7M | $734.7M | $517.5M | $578.5M | $610.2M | $655.7M | $368.6M |
| Liabilities | ||||||||
| Accounts Payable | $14.6M | $13.9M | $21.9M | $18.0M | $13.2M | $9.3M | $7.7M | $4.6M |
| Total Current Liabilities | $48.3M | $45.1M | $53.5M | $41.9M | $33.6M | $21.9M | $25.4M | $26.5M |
| Long-Term Debt | $75.2M | $75.0M | $74.8M | $74.6M | $74.5M | $50.9M | $50.7M | $50.5M |
| Total Liabilities | $125.2M | $122.0M | $130.2M | $118.6M | $110.3M | $75.2M | $78.5M | $79.5M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-991.4M | $-881.9M | $-760.9M | $-669.8M | $-589.5M | $-512.9M | $-461.3M | $-417.8M |
| Total Stockholders' Equity | $407.8M | $499.7M | $604.5M | $398.9M | $468.3M | $535.0M | $577.2M | $289.1M |